Navigation Links
Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology

NAPA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced that Dr. Neil Sadick presented on Pyratine-6(TM) at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio, Texas.

In his presentation to the Academy, Dr. Sadick, a prominent New York dermatologist, outlined the therapeutic benefits of Senetek's Pyratine-6(TM) for the treatment of aging skin. Dr. Sadick reviewed clinical data demonstrating the ability of Pyratine-6(TM) to ameliorate the visible signs of skin aging and significantly reduce erythema -- redness of the skin caused by capillary congestion.

In independent clinical trials at the University of California, Irvine and RCTS, an independent laboratory in Irving, Texas, Pyratine-6(TM) demonstrated significant efficacy in the treatment of fine wrinkles, skin roughness, acne lesions, overall skin aging, and significantly reduced erythema as early as two weeks from onset of use. Pyratine-6(TM) was also shown to increase skin moisture content and was well tolerated by all subjects producing no measurable skin irritation or signs of allergic contact dermatitis with twice-daily application over the 12-week study periods.

Frank Massino, Chairman and Chief Executive Officer of Senetek stated, "We are very pleased by the recognition Pyratine-6(TM) has received at this important dermatological symposium."

About Senetek PLC

Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market.

For more information, visit the company's website at

This news release contains statements that may be considered 'forward- looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2006. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care
2. Womans Day Presents the 5th Annual Red Dress Awards Honoring Women Who Are Leaders in the Fight Against Heart Disease
3. Center for Science Writings presents: Big Fat Lies: The Truth about Diet, Exercise and Obesity
4. IQWiG presents a concept for cost-benefit assessment methods in the German health care system
5. Illness Presents Diabetics With Special Challenges
6. A New Book on Sexual Medicine Calls Attention to The Couple and Presents State-of-the Art Treatments for Sexual Dysfunction
7. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
8. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
9. New book presents comprehensive survey of research into the molecular basis of aging
10. NHCAA Presents 2007 Fraud Investigation of the Year Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy Drug Kingpin
11. National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer
Post Your Comments:
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
(Date:6/24/2016)... Gilbert, Arizona (PRWEB) , ... June 24, 2016 ... ... Gilbert-based practice, is supporting the upcoming 2016 Miss Arizona pageant as its official ... primarily serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: